Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

Sherif M Hamdy,1 Maged Abdel-Naseer,1 Hatem S Shehata,1 Amr Hassan,1 Alaa Elmazny,1 Nevin M Shalaby,1 Noha T Abokrysha,1 Nirmeen A Kishk,1 Mona AF Nada,1 Sandra M Ahmed,1 Mohamed I Hegazy,1 Doaa Mekkawy,1 Husam S Mourad,1 Ahmed Abdelalim,1 Thomas Berger2 1Neurology Department, Faculty of Medicine, C...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hamdy SM, Abdel-Naseer M, Shehata HS, Hassan A, Elmazny A, Shalaby NM, Abokrysha NT, Kishk NA, Nada MAF, Ahmed SM, Hegazy MI, Mekkawy D, Mourad HS, Abdelalim A, Berger T
Format: article
Langue:EN
Publié: Dove Medical Press 2020
Sujets:
covid-19
multiple sclerosis
disease-modifying therapies
Therapeutics. Pharmacology
RM1-950
Accès en ligne:https://doaj.org/article/fcb20240e51846c3ae34c7de93845152
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/fcb20240e51846c3ae34c7de93845152

Documents similaires